i
Use of Tetanus-diphtheria (Td) vaccine in Children 4–7 years of Age: World Health Organization Consultation of Experts
-
5 06 2020
-
-
Source: Vaccine. 38(21):3800-3807
[PDF-125.81 KB]
Details:
-
Alternative Title:Vaccine
-
Personal Author:
-
Corporate Authors:
-
Description:For lifetime protection against diphtheria and tetanus, the World Health Organization (WHO) recommends six doses of diphtheria and tetanus containing vaccines. Td (reduced diphtheria toxoid, ≥2-5 IU) vaccines are currently licensed for ages 7 years and older, but use of Td vaccine for ages 4 years and older would have advantages for immunization programs in many low- and middle-income countries. For this reason, WHO convened an expert consultation to review the currently available evidence for the use of Td vaccine from 4 to 7 years of age which concluded: (1) no relevant biological difference in immune response in the relevant age group compared with children over 7 years of age; (2) adequate seroprotection in several studies with Td vaccine in the 4-7 age group and many studies using combination vaccines; (3) durable and protective response of at least 9-11 years duration in several longitudinal and modelling studies, (4) less reactogenicity compared with use of full-dose diphtheria vaccine, potentially improving the vaccination experience; and (5) adequate control of diphtheria in several countries using Td-containing combination vaccines in 4-7 year old children. On this basis, the experts concluded that from a programmatic perspective, Td vaccine given in ages 4-7 years, as a second booster dose in a six-dose series, would provide adequate protection against diphtheria and tetanus and recommended steps to include this change in age extension listed in the package insert.
-
Subjects:
-
Keywords:
-
Source:
-
Pubmed ID:31983584
-
Pubmed Central ID:PMC7286697
-
Document Type:
-
Funding:
-
Volume:38
-
Issue:21
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
